Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-12 Dworak Leiden Vice President, Finance Grant or award · Stock Option (Right to Buy) +46,875 46,875
2024-01-12 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +160,000 160,000
2023-12-19 BARBERICH TIMOTHY J Director Purchase +317 $4.97 $2K 67,027
2023-12-18 BARBERICH TIMOTHY J Director Purchase +28,830 $4.89 $141K 66,710
2023-12-14 Klencke Barbara Director Purchase +5,000 $5.08 $25K 30,000
2023-12-06 Woods Keith Director Grant or award · Stock Option (Right to Buy) +17,500 17,500
2023-07-21 Dworak Leiden Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2023-06-13 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +35,000 35,000
2023-06-13 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +35,000 35,000
2023-06-13 BARBERICH TIMOTHY J Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2023-06-13 Barton Debora Chief Medical Officer Grant or award · Stock Option (Right to Buy) +430,000 430,000
2023-06-13 Dorton Katina Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2023-06-13 Gruia Gabriela Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2023-06-13 Klencke Barbara Director Grant or award · Stock Option (Right to Buy) +36,524 36,524
2023-06-13 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +632,500 632,500
2023-06-13 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,121,300 1,121,300
2023-06-13 ZDRAVESKI ZORAN Chief Legal Officer Grant or award · Stock Option (Right to Buy) +430,000 430,000
2023-06-02 BARBERICH TIMOTHY J Director Purchase +37,880 $2.63 $100K 37,880
2023-06-01 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +3,192,710 $2.00 $6.4M 3,192,710
2023-06-01 BAKER BROS. ADVISORS LP Director Grant or award · Warrants to purchase Common Stock +34,307,290 $2.00 $68.6M 34,307,290

Page 4 of 8 · 144 trades